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Background: There is evidence of associations between tobacco and cannabis use 
that are consistent with both a classical stepping-stone scenario that posits the 
transition from tobacco use to cannabis use (‘gateway’ effect of tobacco) and 
with the reverse process leading from cannabis use to tobacco abuse (‘reverse 
gateway’ effect of cannabis).   The evidence of direct causal relationships 
between the two disorders is still missing.   
Methods: We analysed data from the Christchurch Health and Development 
Study (CHDS) longitudinal birth cohort using advanced statistical modeling to 
control for fixed sources of confounding and to explore causal pathways.  The 
data were analysed using both: a) conditional fixed effects logistic regression 
modelling; and b) a systematic structural equation modeling approach 
previously developed to investigate psychiatric co-morbidities in the same 
cohort.   
Results: We found significant (p < 0.05) associations between the extent of 
cannabis use and tobacco smoking and vice versa, after controlling for non-
observed fixed confounding factors and for a number of time-dynamic covariate 
factors (major depression, alcohol use disorder, anxiety disorder, stressful life 
events, deviant peer affiliations).  Furthermore, increasing levels of tobacco 
smoking were associated with increasing cannabis use (p = 0.02) and vice versa 
(p < 0.001) over time.  Conclusions: Our results lend support to the notion of both 
of ‘gateway’ and ‘reverse gateway’ effects.  That is, the association between 
tobacco and cannabis use arises from a reciprocal feedback loop involving 
simultaneous causation between tobacco use disorder and cannabis use 
disorder. 
 






Tobacco and cannabis are two of the most abused recreational substances 
worldwide, ranking second and third in prevalence of use after alcohol 
(Degenhardt et al., 2008).  Both tobacco and cannabis are mostly taken via 
smoking (Agrawal et al., 2012), and the two substances are often co-
administered in the form of ‘joints’ or ‘blunts’ (cannabis rolled in cigar paper; 
(Ream et al., 2008). Furthermore, many tobacco and cannabis users are co-users; 
that is, they use the two substances independently of each other either in distinct 
occasions or in a sequence (e.g.: Mayet et al., 2011; Richter et al., 2004). 
A multi-criteria analysis of drug harm (Nutt et al., 2010 ) indicates that 
tobacco and cannabis are among the four most damaging recreational 
substances in terms of direct and indirect economic costs to society. 
Furthermore, it has been proposed that tobacco and cannabis may serve as 
gateway drugs, leading to the use and abuse of other substances (Anthony, 
2012).  Gateway theory has been the subject of some controversy in the 
literature, having been criticized in terms of both drug sequence and causal 
modeling (Baumrind, 1983; Degenhardt et al., 2009; Degenhardt et al., 2010).  
However, it is clear that a better understanding of the factors involved in 
initiating tobacco and cannabis use may shed considerable light on the factors 
responsible for their use. 
Tobacco users who are also cannabis users are more likely to be daily 
smokers and develop dependence than non-cannabis users (Agrawal et al., 2011; 
Degenhardt et al., 2010; Korhonen et al., 2008; Korhonen et al., 2010; Timberlake 
et al., 2007).  On the other hand, tobacco smokers who experiment with cannabis 
are more likely to progress to full-blown cannabis abuse than non-smokers 
(Ream et al., 2008; Timberlake et al., 2007).  Using data collected from the 
National Household Survey on Drug Use and Health (NSDUH) in 2009, Agrawal 
and colleagues (2012) estimated that the probability to develop a cannabis use 
disorder was more than eight times greater in tobacco users than in non-users 
and that the probability to develop nicotine dependence in cannabis users was 
more than three-fold that of non-users.  These findings are consistent both with 




to cannabis use and with the reverse process leading from cannabis use to 
tobacco abuse (reverse gateway effect of cannabis, see:Patton et al., 2005; 
Timberlake et al., 2007; Viveros et al., 2006).  Indeed, there are at least three 
possible explanations for the comorbidity of tobacco and cannabis use disorders.  
First, it is possible to hypothesize the existence of common or correlated genetic 
and/or environmental factors that predispose the individual to both substance 
use disorders.  A second possibility is that the association is caused by tobacco 
acting as a gateway drug to cannabis or vice versa.  Finally, it is possible that the 
associations arise from a reciprocal feedback loop involving simultaneous 
causation between tobacco use disorder and cannabis use disorder. 
Previous studies aimed at investigating these different possibilities have 
not been conclusive.  Mayet and colleagues (2011), for example, used a 
homogenous Markov multi-state model to analyze data from a repeated cross-
sectional survey to estimate the prevalence of tobacco and cannabis use 
disorders and their relationship.  Their findings were compatible with a process 
mixing the gateway theory, the reverse gateway theory, and the route of 
administration model (Agrawal and Lynskey, 2009; Prince van Leeuwen et al., 
2011).  Thus, the authors concluded that longitudinal studies were necessary to 
explore the causal relationship between tobacco use disorder and cannabis use 
disorder.  The need of longitudinal studies has also been stressed by Agrawal and 
colleagues (2012; 2011).   
In the present study, we used data from a 35-year longitudinal study of a 
New Zealand birth cohort to explore the causal relationships between tobacco 
use and cannabis use on the basis of the prevalence and frequency of use at five 
time periods (ages 18, 21, 25, 30 and 35 years).  The data were analysed using 
the same analytic approach previously developed to study the association 
between major depression and both alcohol use disorder (Fergusson et al., 2009) 
and tobacco use (Boden et al., 2010), and between internalizing disorders and 
substance use disorders (Fergusson et al., 2011).  This analytic method 
incorporates: a) the use of conditional fixed-effects regression models, 
augmented by time-dynamic covariate factors, to control for non-observed 
sources of confounding (Hamerle and Ronning, 1995; Hausman et al., 1984; 




analytic approaches allows inferences concerning possible causal associations 
between cannabis use and tobacco smoking, and permits examination of the 
likely direction of causality in the associations between cannabis use and tobacco 







Data were gathered during the course of the Christchurch Health and 
Development Study (CHDS), a study of a birth cohort of 1265 children (635 
males, 630 females) born in the Christchurch (New Zealand) urban region in 
mid-1977.  The cohort has been studied at birth, 4 months, 1 year and annually 
to age 16 years, and again at ages 18, 21, 25, 30, and 35 years (Fergusson and 
Horwood, 2001; Fergusson et al., 1989).  All study information was collected on 
the basis of signed consent from study participants and is fully confidential, and 
is approved by the Canterbury (NZ) Ethics Committee.   
 
2.2 Frequency of cannabis use (ages 17-18, 20-21, 24-25, 29-30, and 34-35 years) 
 
At each assessment at ages 18, 21, 25, 30 and 35 years, cohort members were 
asked about the frequency with which they had used cannabis over the twelve-
month period prior to the assessment.  For the purposes of this analysis, the 
frequency data were classified using a three-level variable with the following 
class intervals: i) no cannabis use; ii) > 0 times and < 1 time per week, and iii) ≥ 1 
time per week.  While these class intervals are somewhat arbitrary, it should be 
noted that, consistent with previous research (Fergusson and Horwood, 2000; 
Fergusson et al., 2002), experimentation with alternative classifications 
produced essentially the same conclusions to those reported here.   
 





At each assessment at ages 18, 21, 25, 30 and 35 years, cohort members were 
asked about the frequency with which they currently smoked cigarettes.  For the 
purposes of this analysis, the smoking frequency data were classified using a 
three-level variable with the following class intervals: i) no tobacco smoking, ii) 
> 0 cigarettes and < 10 cigarettes per day, and iii) ≥ 10 cigarettes per day.  As 
with the cannabis frequency data described above, the use of alternative 
classifications produced similar conclusions to those reported here.   
 
2.4 Time-dynamic covariate factors (ages 18, 21, 25, 30 and 35 years) 
 
In order to control for the effects of possible comorbid mental health and 
substance use disorders and the effects of stressful life events in the analyses, 
four time-dynamic covariate factors were obtained from the study database.  
These included: a) concurrent DSM-IV major depression; b) concurrent DSM-IV 
alcohol use disorder; c) concurrent DSM-IV anxiety disorder; d) a count measure 
of the number of stressful life events experienced during the twelve months 
prior to each assessment; and e) a measure of the number of cohort members' 
deviant peers who either used illicit drugs, or were in trouble in the law.  Further 
details of these measures are given in the Online Supplement. 
 
2.5 Statistical analyses 
 
2.5.1 Associations between frequency of cannabis use and frequency of tobacco 
smoking.  In the first stage of the analyses, the pooled associations between the 
measures of the frequency of cannabis use and tobacco smoking at ages 18, 21, 
25, 30, and 35 years were estimated using Generalized Estimating Equation 
(GEE) methods (Liang and Zeger, 1986; Zeger and Liang, 1986).  Two models 
were fitted: one in which cannabis use predicted tobacco smoking; and a second 
model in which tobacco smoking predicted cannabis use.  In order to address 
issues of non-linear trend in each of the predictors, effect proportional scoring 
methods were used.  Specifications of these models are given in the Online 





2.5.2 Fixed effects model for covariate adjustment.  To adjust the associations 
between cannabis use and tobacco smoking for both: a) non-observed fixed 
sources of confounding; and b) observed time-dynamic covariate factors, 
conditional fixed effects logistic regression models were fitted to the joint data 
for each prediction model (cannabis use predicting tobacco smoking; tobacco 
smoking predicting cannabis use) over the measurement periods (Hamerle and 
Ronning, 1995; Hausman et al., 1984; Judge et al., 1980).  See the Online 
Supplement for a detailed description of the basis for the fixed effects modelling 
and model specification.   
 
2.5.3 Structural equation modelling of reciprocal causal pathways.  To examine the 
possibility of a reciprocal causal relationship in which cannabis use led to 
increased risks of tobacco smoking, and tobacco smoking led to increased risks 
of cannabis use, a structural equation model was fitted to the variance-
covariance matrix of the repeated measures of cannabis use and tobacco 
smoking at each assessment (ages 18, 21, 25, 30, and 35 years), using Mplus and 
weighted least squares estimation.  An example of the reciprocal causal model is 
displayed in Figure 1.   The model assumes that the reported frequency of 
tobacco use at these time periods (t = 1 to 5) is influenced by fixed sources of 
variation (T), which are constant over time, and by time-dynamic sources of 
variation (UT).  Likewise, the reported frequency of cannabis use is influenced by 
fixed sources of variation (C) and by time-dynamic sources of variation (UC).  The 
model allows the fixed factors T and C to be correlated.  The model also assumes 
that UT and UC are linked by autoregressive processes in which past frequencies 
predict future frequencies.   Finally, the model assumes that UT and UC are 
reciprocally related at t = 2, 3, 4, or 5, so that current UT influences current UC 
and vice versa, with these reciprocal effects assumed to be constant over time.  
Further details of the model assumptions and model fitting are provided in the 
Online Supplement.   
 
2.6 Sample size and sample bias 
 




25), 987 (age 30), and 962 (age 35) individuals, representing 76-80% of the 
original cohort.  To examine the effects of sample losses on sample 
representativeness, the obtained samples with complete data at each age were 
compared with the remaining sample members on a series of socio-demographic 
measures collected at birth.  These results suggested that there were statistically 
significant (p < 0.01) tendencies for the obtained samples to under-represent 
individuals from socially-disadvantaged backgrounds.  To address this issue, 
data weighting methods described by Carlin and colleagues (1999) were used to 
re-analyze the data, producing the same pattern of results to those reported 
here, suggesting that the conclusions of this study were unlikely to have been 





3.1 Patterns of cannabis use, tobacco smoking and co-use1 
 
As shown in Fig. 2 and Table 1, more than half of the cohort (54.5%) reported 
smoking tobacco and/or cannabis at age 18 years.  The overall number of users 
peaked at age 21 and progressively decreased, so that at age 35 only 35.3% of 
the cohort was still smoking tobacco and/or cannabis.  Figure 2 also illustrates 
the changes in the prevalence of tobacco and cannabis co-use and indicates that 
the decline in use concerned all types of users and co-users except, those who 
were ‘heavy tobacco smokers-only’ (> 10 cigarettes per day) or ‘heavy cannabis 
users-only’ (≥ 1 time per week).  Figure 3A shows that among ‘tobacco smokers-
only’ the proportion of heavy users more than tripled from age 18 years to age 
35 years.  This was not the case for either ‘cannabis users-only’ or for co-users 
(Fig. 3B and 3C). 
 
 
                                                         
1 Throughout this paper, the term co-use indicates the use of both tobacco and 
cannabis in distinct occasions by the same individual, and not the co-




3.2 Associations between cannabis use and tobacco smoking 
 
Table 1A shows the associations between the frequency of cannabis use and the 
probability of being a tobacco smoker at ages 18, 21, 25, 30, and 35 years.  Table 
1B shows the frequency of tobacco smoking and the probability of using 
cannabis at ages 18, 21, 25, 30, and 35 years.  The data in both tables were 
analysed using a random effects GEE model to estimate the associations 
between: i) cannabis use and tobacco smoking, and ii) tobacco smoking and 
cannabis use.  Both analyses show the presence of strong linear associations (p < 
0.0001) between the extent of cannabis/tobacco use and the probabilities of 
tobacco smoking/cannabis use, as indicated by the relative OR’s.   
 
 
3.3 Adjustments for confounding 
 
Tables 2A and 2B show the results of analyses controlling for both i) non-
observed fixed confounding factors; and ii) a number of time-dynamic covariate 
factors, including: major depression; alcohol use disorder; anxiety disorder;  
stressful life events; and deviant peer affiliations.  Table 2A shows the estimates 
of the covariate-adjusted coefficients for the prediction of smoking from 
cannabis use and Table 2B those for the prediction of cannabis use from 
smoking.  Both analyses showed that control for non-observed fixed factors and 
time-dynamic covariate factors reduced the magnitude of the associations 
between tobacco smoking and cannabis use.  Nonetheless, the adjusted 
associations remained statistically significant (p < 0.05) and substantial, 
suggesting that the associations between cannabis use and tobacco smoking 
could not be accounted for by non-observed sources of confounding, or time-
dynamic covariate factors.  
 
 
3.4 Testing for Reverse Causality 
 




the associations between cannabis use and tobacco smoking: 1) cannabis use 
leads to tobacco smoking; 2) tobacco smoking leads to cannabis use; and 3) there 
is a reciprocal causal relationship in which both 1) and 2) hold simultaneously.  
One advantage of longitudinal data is that it is possible to fit structural equation 
models (SEMs) that permit reciprocal causal pathways (Boden et al., 2010); 
(Fergusson et al., 2009).  To examine this possibility, the SEM depicted in Figure 
1 was fitted to the data (see Methods) using Mplus2.  The method of modeling 
(described in detail in the Online Supplement) estimates two key parameters of 
interest: i) the parameter B1 reflecting the causal effect of cannabis use on the 
level of tobacco smoking, and ii) the parameter B2 reflecting the causal effect of 
tobacco smoking on the level of cannabis use.  
The model depicted in Figure 1 was fitted to the repeated measures data 
on levels of tobacco use and cannabis use over the five time periods from age 18-
35.  The model showed an excellent fit to the observed data [model χ2(25) = 
32.7, p = 0.14; RMSEA = 0.019; CFI = 0.99].  Further, the model showed that after 
control for non-observed fixed sources of confounding, there was evidence of 
modest but statistically significant reciprocal associations in which: i) increasing 
levels of cannabis use were associated with increasing tobacco smoking (B1 = 
0.099; SE = 0.030; 95% CI: .040-.158; p < 0.001), and ii) increasing levels of 
tobacco smoking were associated with increasing cannabis use (B2 = 0.066; SE = 




The present study analysed data from the Christchurch Health and Development 
Study (CHDS) longitudinal birth cohort using advanced statistical modeling to 
control for fixed sources of confounding, and to explore causal pathways in the 
associations between cannabis use and tobacco smoking.  The findings of these 
analyses and their implications are outlined below.   
 
4.1 Patterns of tobacco smoking and cannabis use 
                                                         






More than half of the CHDS cohort reported using tobacco and/or cannabis at 
age 18 years, with an overall prevalence of 54.5%.  At this age, most of these 
users (regardless of the frequency of use) were co-users.  This pattern is 
consistent with previous studies investigating a similar age bracket (e.g.: 
Agrawal et al., 2011).  The overall prevalence of use peaked at age 21 and then 
progressively decreased to 35.3% by age 35 years.   
However, age-dependent changes in the prevalence of use were very 
different as a function of drug and of intensity of use.  The prevalence of use at 
age 35 years was in fact half that observed at age 18 years for light (< weekly) 
and heavy (≥ weekly) cannabis users (−47.5% and −43.75%, respectively), and 
for light tobacco smokers (< 10 cigarettes per day; −59.1%).  In contrast, the 
prevalence of heavy tobacco smoking at age 35 years was exactly the same 
observed at age 18 years.  More specifically, there was an age-related decline for 
all types of users and co-users, except for those who were ‘heavy tobacco 
smokers-only’ or ‘heavy cannabis users-only’ (see Fig. 1), indicating the 
emergence of more selective drug preferences.  This was particularly true of 
heavy tobacco smokers-only, whose prevalence increased more than 200% from 
age 18 years to age 35 years (see Fig. 1C and 2A) whereas for heavy cannabis 
users-only the increase was only by 31%, confirming that the addictive potential 
of tobacco is much greater than that of cannabis, whereas the probability of 
remission from dependence is much lower (Lopez-Quintero et al., 2011a; Lopez-
Quintero et al., 2011b). 
An important aspect of the CHDS birth cohort is that the prevalence of use 
for cannabis-only was comparable to that for tobacco-only at ages 18 and 35, a 
pattern that is characteristic of New Zealand and Australia (e.g.: Degenhardt et 
al., 2008; Swift et al., 2012) and that stands in sharp contrast with that observed 
in most other countries, where the prevalence of tobacco use is much higher 
than that of cannabis (e.g.: Agrawal et al., 2012; Degenhardt et al., 2008).  The 
similarity in the prevalence of tobacco and cannabis use is ideally suited to 
investigate the reciprocal influences between the two conditions.   
 





In agreement with previous studies (Agrawal et al., 2011; Degenhardt et al., 
2010; Korhonen et al., 2008; Korhonen et al., 2010; Ream et al., 2008; 
Timberlake et al., 2007), we found a significant association between tobacco 
smoking and cannabis use.  Light cannabis users had approximately five times 
greater odds of being tobacco smokers than non-users.  Also the odds of light 
tobacco smokers of being cannabis users were about five-fold those of non-
smokers.  The odds of co-use greatly increased in heavy users.  Both heavy 
tobacco smokers and heavy cannabis users were about thirty times more likely 
to co-use the other substance than the respective non-users.   
One possible explanation for these associations is that they arose because 
of common confounding factors, including non-observed fixed effects as well as 
time dynamic covariate factors, such as concurrent psychiatric disorders (major 
depression, alcohol use disorder, and anxiety disorder), stressful life events and 
deviant peer affiliations.  However, significant and robust associations remained 
evident even after adjustment for both non-observed fixed confounding and 
time-dynamic covariate factors, suggesting that the associations between 
cannabis use and tobacco use could not be explained by confounding.  After 
adjustment, light users of either substance had approximately three times the 
adjusted odds of also using the other substance relative to the respective non-
users.  In heavy users of either substance the adjusted odds were seven to eight 
times greater than those of the respective non-users.  This pattern of findings 
suggests a possible reciprocal causal association in which cannabis use increases 
the risk of tobacco use, and vice-versa. 
To explore the possible pathways between tobacco smoking and cannabis 
use structural equation modeling was used to fit a reciprocal causation model. 
This analysis suggested that the best-fitting model was one in which there was a 
bidirectional association between tobacco smoking and cannabis smoking, in 
which: i) the use of one substance leads to the use the other substance; and ii) 
the greater the intensity of use of one substance the greater the intensity of use 
of the other substance. 
To the best of our knowledge, this is the first longitudinal study to 




cannabis use.  Our findings confirm and extend those other longitudinal studies 
concerned with unidirectional influences of tobacco use on cannabis use or vice 
versa.  A 10-year cohort study conducted by Patton and colleagues (2005) 
investigated the role of cannabis use in the later initiation of tobacco use and 
progression to dependence.  They found that at least one report of weekly 
cannabis use in the teens was associated to a more than eight-fold increase in the 
odds of later initiation of tobacco use whereas daily cannabis use at age 21 years 
was associated to a more than three-fold increase in the odds of progressing to 
tobacco dependence.  A more recent longitudinal study by Prince van Leeuwen 
and colleagues (2014) examined whether tobacco use during adolescence 
affected the likelihood to abuse cannabis.  They found that both early-onset 
tobacco use and continued tobacco use in adolescence doubled the likelihood of 
developing a cannabis use disorder.  
The findings reported here have important implications for the ‘gateway’ 
hypotheses, which posits a progression in drug use, beginning with tobacco and 
alcohol, moving on to cannabis, and then to other illicit drugs (Botvin et al., 2000; 
Kandel and Faust, 1975; Kandel, 1984; Kandel et al., 1992; Lynskey et al., 2003).  
The nature of these “gateway” effects is a matter of some debate (Degenhardt et 
al., 2010; Fergusson et al., 2006; Kandel et al., 2006; MacCoun, 2006; Morral et 
al., 2002; Prince van Leeuwen et al., 2011; Vanyukov et al., 2012). In particular, it 
is not clear whether the predictive association between cannabis and other illicit 
drug use is causal or reflects confounding factors (Fergusson et al., 2006; Hall 
and Lynskey, 2005; Kandel and Faust, 1975; Kandel, 1984; Kandel et al., 2006; 
MacCoun, 2006; Morral et al., 2002).  Furthermore, there is data suggesting a 
“reverse gateway” effect of cannabis use on tobacco use (Patton et al., 2005; 
Viveros et al., 2006). The systematic structural equation model used in the 
present study indicates the simultaneous occurrence of ‘gateway’ and ‘reverse 
gateway’ effects.  That is, the association between tobacco and cannabis use 
arises from a reciprocal feedback loop involving simultaneous causation 
between tobacco use and cannabis use.    
With the present study adding to the growing evidence concerning a 
possible gateway role of tobacco in linkages with cannabis and other illicit drugs, 




The route of administration model (Agrawal and Lynskey, 2009) would suggest 
that the origins of these linkages are either physiological or cultural in nature, in 
which the use of either tobacco or cannabis is increased by: a) the act of smoking 
one or the other substance causes aero-respiratory changes; and/or b) social and 
cultural practices in which tobacco and cannabis are consumed simultaneously 
(via "joints" or "blunts").  Further research is necessary to better distinguish 
between these accounts of the linkages between tobacco and cannabis use. 
A further possible explanation for the observed associations between 
cannabis and tobacco is the common liability model (Prince van Leeuwen et al., 
2011), in which genetic and individual factors are thought to increase the risk of 
the use of multiple substances.  However, it would seem to be the case that such 
factors should have been accounted for in the present analyses by: a) the use of 
conditional fixed-effects models; and b) the correlated latent indices for cannabis 
and tobacco in the structural models. 
 
4.3 Limitations of the study 
 
It is important to recognize that the conclusions drawn in this analysis rely on 
some underlying assumptions.  The most pervasive of these assumptions is that 
the pattern of causal relationships can be modeled as a stable causal process that 
was operative throughout the course of this study.  This is clearly a strong 
assumption, but it is essential for both the fixed-effects and reciprocal-causes 
models.  Additional research is required to verify whether our assumption is 
correct.  It is also possible that our structural equations do not adequately reflect 
the complexity of all the factors at play, an issue that can be addressed only by 
further investigations based on models partly or radically different from the one 
used here.  Finally, it should also be noted that specific instances of co-use of 
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Table 1a  Associations between frequency of cannabis use and probability 
of tobacco smoking, ages 18, 21, 25, 30, and 35 years 
 
Age Level of cannabis use n % reporting tobacco smoking 
18 None 598 22.1 
 < weekly 329 56.5 
 ≥ weekly 98 83.7 
    
21 None 538 23.4 
 < weekly 340 54.4 
 ≥ weekly 133 69.2 
    
25 None 559 26.3 
 < weekly 353 49.3 
 ≥ weekly 91 67.0 
    
30 None 657 21.5 
 < weekly 262 45.0 
 ≥ weekly 68 72.1 
    
35 None 747 16.7 
 < weekly 163 41.7 
 ≥ weekly 52 61.5 
    
Population-averaged rates: % OR (95% CI) 
 None 21.7 1 (--) 
 < weekly 49.9 5.30 (4.24-6.62) 





Table 1b  Associations between frequency of tobacco smoking and 
probability of  cannabis use, ages 18, 21, 25, 30, and 35 years 
 
Age Level of cigarette smoking n % reporting cannabis use 
18 None 625 25.4 
 < 10/day 271 60.1 
 10+/day 129 81.4 
    
21 None 608 37.2 
 < 10/day 221 66.5 
 10+/day 182 71.4 
    
25 None 621 33.7 
 < 10/day 203 52.7 
 10+/day 179 71.6 
    
30 None 677 23.8 
 < 10/day 149 47.0 
 10+/day 161 61.5 
    
35 None 737 15.6 
 < 10/day 104 45.2 
 10+/day 121 43.8 
    
Population-averaged rates: % OR (95% CI) 
 None 25.7 1 (--) 
 < 10/day 56.3 5.51 (4.49-6.76) 





Table 2a Associations between frequency of cannabis use and probability 
of tobacco smoking, after adjustment for both: a) non-observed fixed 
sources of confounding; and b) time-dynamic covariate factors 
 
 Cigarette smoking 
Level of cannabis use OR (95% CI) 
None 1 (--) 
< weekly 2.90 (2.34-3.58) 
≥ weekly 8.41 (5.48-12.82) 
Statistically significant (p<.05) time dynamic covariate factors: major 




Table 2b Associations between frequency of tobacco smoking and 
probability of cannabis use, after adjustment for both: a) non-observed 
fixed sources of confounding; and b) time-dynamic covariate factors 
 
 Cannabis use 
Level of cigarette smoking OR (95% CI) 
None 1 (--) 
< 10/day 2.69 (2.21-3.28) 
10+/day 7.24 (4.88-10.76) 
Statistically significant (p<.05) time dynamic covariate factors: major 

















Prevalence of use in the past 12 months at ages 18, 21, 25, 30, and 35 years, for: 
A) ‘light tobacco smokers-only’ (< 10 cigarettes per day), ‘light cannabis users-
only’ (< 1 time per week), and light co-users; B) ‘heavy tobacco smokers-only’ (> 
10 cigarettes per day), ‘heavy cannabis users-only’ (≥ 1 time per week), and 
heavy co-users; C) heavy tobacco-light cannabis co-users and light tobacco-







Proportion of light versus heavy use (at ages 18, 21, 25, 30, and 35 years) for: A) 
tobacco smokers-only; B) cannabis users-only; C) co-users.  For the definition of 
‘light’ and ‘heavy’ see text and Fig. 1 
